Motilent is a technology startup on a mission to change the way we see the gut. Specializing in the assessment of digestive diseases using medical image analysis, their main focus areas include Crohn’s Disease, Irritable Bowel Syndrome (IBS) and Gastroparesis. Motilent’s first product GIQuant aims to help clinicians to identify earlier when patients stop responding to immunotherapy.